ArticleBlood neoplasia2026

Fixed-treatment duration venetoclax following covalent BTKi progression in chronic lymphocytic leukemia.

Isabelle Fleury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.